ATE264925T1 - Oligonukleotidstartermoleküle zur effizienten multiplexdetektion vom hepatitis c virus (hcv) und vom humanen immundefizienzvirus (hiv) und methoden zu ihrer verwendung - Google Patents

Oligonukleotidstartermoleküle zur effizienten multiplexdetektion vom hepatitis c virus (hcv) und vom humanen immundefizienzvirus (hiv) und methoden zu ihrer verwendung

Info

Publication number
ATE264925T1
ATE264925T1 AT00300789T AT00300789T ATE264925T1 AT E264925 T1 ATE264925 T1 AT E264925T1 AT 00300789 T AT00300789 T AT 00300789T AT 00300789 T AT00300789 T AT 00300789T AT E264925 T1 ATE264925 T1 AT E264925T1
Authority
AT
Austria
Prior art keywords
virus
hepatitis
methods
hcv
hiv
Prior art date
Application number
AT00300789T
Other languages
English (en)
Inventor
Kevin M Gorman
David R Patterson
Jeffrey M Linnen
Keming Song
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE264925T1 publication Critical patent/ATE264925T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00300789T 1999-02-03 2000-02-01 Oligonukleotidstartermoleküle zur effizienten multiplexdetektion vom hepatitis c virus (hcv) und vom humanen immundefizienzvirus (hiv) und methoden zu ihrer verwendung ATE264925T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11849899P 1999-02-03 1999-02-03

Publications (1)

Publication Number Publication Date
ATE264925T1 true ATE264925T1 (de) 2004-05-15

Family

ID=22378976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00300789T ATE264925T1 (de) 1999-02-03 2000-02-01 Oligonukleotidstartermoleküle zur effizienten multiplexdetektion vom hepatitis c virus (hcv) und vom humanen immundefizienzvirus (hiv) und methoden zu ihrer verwendung

Country Status (13)

Country Link
US (1) US6623919B1 (de)
EP (1) EP1035220B1 (de)
JP (1) JP5442917B2 (de)
KR (1) KR100910545B1 (de)
CN (1) CN1213150C (de)
AT (1) ATE264925T1 (de)
AU (1) AU783171C (de)
CA (1) CA2296044C (de)
DE (1) DE60009977T2 (de)
DK (1) DK1035220T3 (de)
ES (1) ES2218067T3 (de)
NO (1) NO328535B1 (de)
PT (1) PT1035220E (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE456677T1 (de) * 1999-07-09 2010-02-15 Gen Probe Inc Hiv-1 detektion mittels nukleinsäureamplifizierung
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
US7255996B2 (en) 2003-12-19 2007-08-14 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2147118A4 (de) * 2007-04-27 2010-09-01 Eragen Biosciences Inc Materialien und verfahren zum nachweis von hepatitis-c-virus
CN102171366B (zh) * 2008-07-31 2014-11-26 奥西泰克有限公司 多重扩增与检测
CN104120194B (zh) * 2014-08-08 2016-05-18 卫生部北京医院 一种病毒rna检测引物的设计方法及试剂盒
US10858711B2 (en) 2015-02-23 2020-12-08 University Of Washington Primers, probes and methods for sensitive, specific detection and monitoring of HIV-1 and HCV
CN106011309A (zh) * 2016-05-20 2016-10-12 凯杰生物工程（深圳）有限公司 用于检测人丙型肝炎病毒的引物组和探针
JP7203017B2 (ja) * 2016-09-07 2023-01-12 セイント ヴィンセンツ ホスピタル シドニー リミテッド レンチウイルスを検出する方法
CN110892082A (zh) * 2017-10-03 2020-03-17 雅培分子公司 丙型肝炎病毒(hcv)的测定

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US5491225A (en) * 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
US5747244A (en) 1991-12-23 1998-05-05 Chiron Corporation Nucleic acid probes immobilized on polystyrene surfaces
WO1994012670A2 (en) * 1992-11-27 1994-06-09 N.V. Innogenetics S.A. Process for typing of hcv isolates
IT1284847B1 (it) * 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
AU783171B2 (en) 2005-09-29
JP2000279198A (ja) 2000-10-10
ES2218067T3 (es) 2004-11-16
EP1035220B1 (de) 2004-04-21
AU1482800A (en) 2000-08-03
DK1035220T3 (da) 2004-08-16
DE60009977T2 (de) 2005-08-04
JP5442917B2 (ja) 2014-03-19
CN1213150C (zh) 2005-08-03
PT1035220E (pt) 2004-09-30
CA2296044A1 (en) 2000-08-03
EP1035220A2 (de) 2000-09-13
CN1268575A (zh) 2000-10-04
NO20000514L (no) 2000-08-04
KR100910545B1 (ko) 2009-08-03
NO328535B1 (no) 2010-03-15
CA2296044C (en) 2009-01-13
US6623919B1 (en) 2003-09-23
DE60009977D1 (de) 2004-05-27
EP1035220A3 (de) 2001-08-22
AU783171C (en) 2006-07-13
NO20000514D0 (no) 2000-02-01
KR20000076598A (ko) 2000-12-26

Similar Documents

Publication Publication Date Title
DE60038993D1 (de) Oligonukleotidprimer zur reversen Transkription für den effizienten Nachweis von HIV-1 und HIV-2 und Methoden ihrer Verwendung
DE60041940D1 (de) Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
ATE264925T1 (de) Oligonukleotidstartermoleküle zur effizienten multiplexdetektion vom hepatitis c virus (hcv) und vom humanen immundefizienzvirus (hiv) und methoden zu ihrer verwendung
DE69929882D1 (de) Verfahren und vorrichtung zur nukleinsäurereinigung
DE69838513D1 (de) Verkürztes hepatitis-c-virus protein nsb5 und methoden, um antivirale substanzen zu identifizieren
DE69939388D1 (de) Identizierung von microorganismen,die akute atemwegsinfektionen verursachen
ATE142276T1 (de) Nukleotid-sequenzen nützlich als typenspezifische sonden, pcr primers und lcr sonden zur amplifikation und zum nachweis von humanem papillomavirus, sowie dazu verwendete kits und verfahren
DE69933121D1 (de) Methode, reagent und testsatz zur typisierung des genoms von papillomavirus
DE69823372T8 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
ATE340998T1 (de) Verfahren zur bestimmung von flüchtigen substanzen in lösung
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
ATE359293T1 (de) Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
DE60045387D1 (de) Verfahren, vorrichtung und system zur kondensation von dämpfe und gase
MC2470A1 (fr) Prodrogues inhibitrices de la protéase du virus dl'immunodéficience humaine (vih) et leur vectoridation vers le système nerveux central (snc)
NZ512954A (en) Integrated device including a DNA, RNA or protein trap for biological sample preparation
ATE481415T1 (de) Verfahren zur selektion von hiv-1 subtyp c- isolaten, solche isolaten, sowie deren gene, modifikationen und ableitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1035220

Country of ref document: EP